This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Gyeonggido Business & Science Accelerator, Korea University Research and Business Foundation, Korpharm Co., Ltd.. Active years: 2023.
Company Filing History:
1 out of 3 
1 out of 1,262 
1 out of 1 Years Active: 2023
Title: Serk In Park: Innovator in Pharmaceutical Composition
Introduction
Serk In Park is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can aid in the treatment of serious health conditions.
Latest Patents
Serk In Park holds a patent for a benzylideneacetone derivative and its uses. The invention relates to novel benzylideneacetone derivatives, specifically a pharmaceutical composition aimed at preventing or treating cancer or bone diseases. The active ingredient in this composition is defined by a specific formula or its pharmaceutically acceptable salt.
Career Highlights
Throughout his career, Serk In Park has worked with various organizations, including Korpharm Co., Ltd. and the Gyeonggido Business & Science Accelerator. His work in these companies has allowed him to advance his research and contribute to innovative solutions in the pharmaceutical industry.
Collaborations
Some of his notable coworkers include Gil Hong Park and Jin Mo Ku. Their collaboration has likely fostered an environment of innovation and creativity in their respective projects.
Conclusion
Serk In Park's contributions to pharmaceutical compositions demonstrate his commitment to advancing medical science. His innovative work continues to impact the field positively.